0
0

Chapter 54. Treatment of Bipolar Disorder

Paul E. Keck, M.D.; Susan L. McElroy, M.D.
DOI: 10.1176/appi.books.9781585623860.443573

Sections

Excerpt

Bipolar disorder is a common, recurrent, often severe psychiatric illness that, without adequate treatment, is associated with high rates of morbidity and mortality (Goodwin and Jamison 2007). In the Global Burden of Disease survey, bipolar disorder was the sixth leading cause of disability worldwide in 1990 and, without improved access to treatment, was projected to remain so well into this century (Murray and Lopez 1996). Morbidity from bipolar disorder often extends well beyond manic, hypomanic, mixed, and depressive episodes. Full recovery of functioning can lag many months behind symptomatic improvement, and repeated episodes can lead to lasting functional impairment (Judd et al. 2005). Recent naturalistic outcome studies indicate that many patients with bipolar disorder spend protracted periods of time neither well nor syndromally ill but rather suffering from chronic subsyndromal, especially depressive, symptoms (Judd et al. 2002, 2003). Bipolar disorder is also among the most heritable of all medical illnesses (Goodwin and Jamison 2007).

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

References

+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
A number of new atypical antipsychotic medications and antiepileptic agents are being studied as potential antimanic agents. Thus far, however, the only randomized, controlled clinical trial to demonstrate efficacy was for
2.
A 62-year-old woman is referred to you by a primary care colleague for evaluation of depression. After obtaining a detailed history, you make a diagnosis of bipolar II disorder with a current episode of depression. To avoid precipitating a switch from depression to mania, a prudent medication strategy for this patient would be to
3.
Which of the following mood stabilizers has demonstrated efficacy as monotherapy for acute bipolar depression?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 3.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 4.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 11.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Topic Collections
Psychiatric News
PubMed Articles
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation